These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Interleukin-2 injections produce sustained increases in CD4+ T cell counts in early-stage HIV disease. AIDS Patient Care STDS; 1996 Oct; 10(5):312. PubMed ID: 11361533 [No Abstract] [Full Text] [Related]
6. Interleukin-2 as therapy for HIV disease. Dinitrochlorobenzene Study Group. Goldberg B N Engl J Med; 1995 Jul; 333(3):192; author reply 193. PubMed ID: 7791830 [No Abstract] [Full Text] [Related]
7. Immune-based therapies. Lein B PI Perspect; 1995 Dec; (no 17):16-8. PubMed ID: 11363108 [TBL] [Abstract][Full Text] [Related]
8. Interleukin-2 as therapy for HIV disease. Disla E N Engl J Med; 1995 Jul; 333(3):192; author reply 193. PubMed ID: 7646690 [No Abstract] [Full Text] [Related]
9. Interleukin-2 as therapy for HIV disease. Landonio G; Baiocchi C; Ferrari M N Engl J Med; 1995 Jul; 333(3):192-3. PubMed ID: 7791831 [No Abstract] [Full Text] [Related]
11. A new approach: immune-based treatments against HIV. Berger DS Posit Aware; 2007; 18(3):43-4. PubMed ID: 17526118 [No Abstract] [Full Text] [Related]
12. Approaches to immune reconstitution in HIV infection. Napolitano LA Top HIV Med; 2003; 11(5):160-3. PubMed ID: 14555803 [No Abstract] [Full Text] [Related]
13. Update on immune-based therapies. PI Perspect; 1996 Nov; (No 20):10-4. PubMed ID: 11363965 [TBL] [Abstract][Full Text] [Related]
14. Increasing CD4 count with interleukin-2 does not benefit people with HIV. Roehr B BMJ; 2009 Feb; 338():b615. PubMed ID: 19218320 [No Abstract] [Full Text] [Related]
17. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications]. Theze J Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368 [TBL] [Abstract][Full Text] [Related]
18. A case of multidrug resistant primary HIV infection with delayed CD4 T-cell count decline despite low viral load, treated with interleukin-2. Pao D; Smit E; Imami N; Fisher M AIDS; 2006 Jul; 20(11):1564-5. PubMed ID: 16847417 [No Abstract] [Full Text] [Related]
19. The value of preserving HIV-specific immune responses. Kaufmann DE; Rosenberg ES J HIV Ther; 2003 Feb; 8(1):19-25. PubMed ID: 12840711 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-2 in HIV infection. Minor JR Am J Health Syst Pharm; 1995 Jun; 52(12):1345-6. PubMed ID: 7656123 [No Abstract] [Full Text] [Related] [Next] [New Search]